Loading clinical trials...

Evaluation of Treatment Satisfaction and Preference for Sumavel DosePro in the Treatment of Migraine | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 4NCT01016834

Evaluation of Treatment Satisfaction and Preference for Sumavel DosePro in the Treatment of Migraine

The purpose of the study is to evaluate the treatment satisfaction of subjects using Sumavel DosePro to treat their moderate to severe migraines.

Lead sponsor: Zogenix, Inc.•21 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGNA

Chiropractic Care for Episodic Migraine

NCT06229834 · Episodic Migraine

RECRUITING

Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the Prevention of Chronic or Episodic Migraine

NCT06603558 · Chronic Migraine, Episodic Migraine, and more

RECRUITINGNA

BE WELL With Migraine: Brain Education and WELLness With Migraine

NCT05987592 · Migraine

RECRUITING

i-NEED: NEw migrainE Drugs Database

NCT07103694 · Episodic Migraine, Chronic Migraine, and more

RECRUITINGPhase 3

A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine

NCT06616194 · Migraine

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 8, 2026Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE4

Enrollment246

Start dateNov 2009

Last updatedJun 8, 2026

Condition

Migraine

Locations shown

University of Alabama Hospital, Dept. of Neurology

Birmingham, Alabama

Arizona Research Center

Phoenix, Arizona

C. Phillip O'Carroll, MD, Inc

Newport Beach, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 8, 2026Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions